Diana DeGette actually said...

We need a full panoply of investment in the research, the basic science, the drug discovery and drug development that lasts.

The bacterium's resistance to colistin is particularly concerning because in this country physicians use colistin as the treatment of last r...

We have been worried for quite some time here in Congress and at the agencies about the risk of resistant antibiotics.

myself and Congressman Bilirakis have introduced a bill that talks about lowering drug costs through competition.